Right now, fentanyl-related substances—drugs that are chemically similar to fentanyl—are temporarily banned under federal law, but that temporary ban is set to expire on March 31, 2025. This bill would make that ban permanent instead of letting it expire. What this means in practical terms is that fentanyl analogues would stay classified as Schedule I drugs, the strictest category under federal law. Schedule I drugs are considered to have no legitimate medical use and a high potential for abuse, so they come with serious criminal penalties for manufacturing, distributing, or possessing them. Without this bill, the temporary ban would disappear, and these dangerous synthetic opioids could potentially become legal again—a major concern given the ongoing fentanyl overdose crisis. By making the ban permanent, the bill ensures that law enforcement can continue to prosecute people who make or sell these substances, and it prevents drug manufacturers from exploiting the expiration date to legally produce new fentanyl-like drugs. Essentially, this is a straightforward measure to keep a drug control measure in place rather than letting it lapse.

Stopping Overdoses of Fentanyl Analogues Act

Fitzgerald, Scott

Stopping Overdoses of Fentanyl Analogues ActThis bill permanently adds fentanyl-related substances to schedule I of the Controlled Substances Act. (A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.)Fentanyl-related substances are currently regulated under schedule I through a temporary order issued by the Drug Enforcement Administration. The temporary order expires March 31, 2025.